CIB1 is an endogenous inhibitor of agonist-induced integrin αIIbβ3 activation

Creator

Yuan, Weiping
- University of North Carolina at Chapel Hill
Leisner, Tina M.
- University of North Carolina at Chapel Hill
McFadden, Andrew W.
- University of North Carolina at Chapel Hill
Wang, Zhengyan
- University of North Carolina at Chapel Hill
Larson, Mark K.
- University of North Carolina at Chapel Hill
- Other Affiliation: University of Birmingham
Clark, Shantres
- University of North Carolina at Chapel Hill
Boudignon-Proudhon, Christel
- University of North Carolina at Chapel Hill
Lam, Stephen C.T.
- Other Affiliation: University of Illinois at Chicago
Parise, Leslie V.
- University of North Carolina at Chapel Hill

Abstract

In response to agonist stimulation, the αIIbβ3 integrin on platelets is converted to an active conformation that binds fibrinogen and mediates platelet aggregation. This process contributes to both normal hemostasis and thrombosis. Activation of αIIbβ3 is believed to occur in part via engagement of the β3 cytoplasmic tail with talin; however, the role of the αIIb tail and its potential binding partners in regulating αIIbβ3 activation is less clear. We report that calcium and integrin binding protein 1 (CIB1), which interacts directly with the αIIb tail, is an endogenous inhibitor of αIIbβ3 activation; overexpression of CIB1 in megakaryocytes blocks agonist-induced αIIbβ3 activation, whereas reduction of endogenous CIB1 via RNA interference enhances activation. CIB1 appears to inhibit integrin activation by competing with talin for binding to αIIbβ3, thus providing a model for tightly controlled regulation of αIIbβ3 activation.

Date of publication

Keyword

DOI

Identifier

Resource type

Rights statement

Journal title

Journal volume

Journal issue

Page start

Page end

Language

ISSN

Relations

Thumbnail	Title	Date Uploaded	Visibility	Actions
	EuropePMC-PMC2063547.pdf	November 1, 2020	Public	Download